Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Stock Info Message Board

Sevion Therapeutics Inc. (SVON) News Nov 14, 2014,

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 250675
Posted On: 11/17/2014 4:17:35 AM
Posted By: Savant
Sevion Therapeutics Inc. (SVON) News Nov 14, 2014, 4:00 p.m.
MarketWatch News on SVON
No News currently available for SVON
Advertisement
Other News on SVON
10-Q: SEVION THERAPEUTICS, INC. 3:51 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: SENESCO TECHNOLOGIES INC 7:01 a.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: SENESCO TECHNOLOGIES INC 2:20 p.m. May 9, 2014 - Edgar Online - (EDG = 10Q, 10K)
A New Trial Combining Fabrus And Senseco Technologies May Be Close At Hand 11:22 a.m. Feb. 13, 2014 - Seeking Alpha
Interview With Fabrus President Dr. Vaugh Smider 5:01 a.m. Jan. 14, 2014 - Seeking Alpha
Senesco Offers A New Approach To Cancer Treatment And Dr. Phillip Frost Is Now With The Company 2:24 p.m. Jan. 8, 2014 - Seeking Alpha
Senesco signs LoI to merge with Fabrus 10:26 a.m. Dec. 30, 2013 - Seeking Alpha
Senesco: Near-Term Catalyst Could Double Shareprice 11:12 a.m. Dec. 27, 2013 - Seeking Alpha
Senesco Heading In The Right Direction With A Unique Cancer Therapy Technology 1:19 p.m. Dec. 13, 2013 - Seeking Alpha
Why Positive Results For Cohort 3 Had Counterintuitive Effect On Senesco 12:07 p.m. Dec. 10, 2013 - Seeking Alpha
10-Q: SENESCO TECHNOLOGIES INC 3:57 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
As Dosage Escalates, So Could The Market Valuation Of Senesco 10:32 a.m. Nov. 8, 2013 - Seeking Alpha
Senesco Technologies: A Potential $26 Stock Trading At $5 11:09 a.m. Nov. 4, 2013 - Seeking Alpha
10-K: SENESCO TECHNOLOGIES INC 4:02 p.m. Sept. 11, 2013 - Edgar Online - (EDG = 10Q, 10K)
3 Penny Stock Patterns to Watch 7:45 a.m. July 17, 2013 - InvestorPlace.com
Press Releases on SVON
Sevion Therapeutics to Present at 13th Annual BIO Investor Forum 7:15 a.m. Oct. 6, 2014 - BusinessWire - BZX
Senesco Announces New CEO 1:30 p.m. June 25, 2014 - BusinessWire - BZX
Senesco Technologies, Inc. - Dr. Harlan Waksal: "The Powerful Possibilities Behind the Senesco/Fabrus Combination" 7:17 a.m. June 10, 2014 - ACCESSWIRE
Senesco Completes Acquisition of Fabrus, An OPKO Portfolio Company 1:22 p.m. May 19, 2014 - BusinessWire - BZX
Senesco Technologies, Inc. - "Reconsidering the Entire Cancer Treatment Approach" 10:47 a.m. April 1, 2014 - ACCESSWIRE
Senesco to Provide Update on Its Phase 1b/2a Trial Progress at 55th American Society of Hematology Annual Meeting 8:00 a.m. Nov. 12, 2013 - BusinessWire
TrendingWallStreet.com Releases Volume Analysis on STP, SNTID, PGLO, and VELT 12:18 a.m. Nov. 5, 2013 - ACCESSWIRE
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 1:10 p.m. Oct. 31, 2013 - GlobeNewswire
Senesco Opens New Clinical Trial Site at Seattle Cancer Care Alliance and is Treating the First West Coast Patient 7:00 a.m. Oct. 23, 2013 - BusinessWire
Senesco Announces $1.725 Million Equity Financing 7:00 a.m. Oct. 1, 2013 - BusinessWire
Senesco Technologies Reports Fiscal Year 2013 Financial Results 7:30 a.m. Sept. 12, 2013 - BusinessWire
Senesco Announces Results of Cohort 2 of its SNS01-T Phase 1b/2a Trial 7:30 a.m. June 19, 2013 - BusinessWire
Senesco Technologies Reports Second Quarter Fiscal 2013 Financial Results 7:30 a.m. May 16, 2013 - BusinessWire
Senesco Announces Presentation on Combination Therapy with Novel Nanoparticle, SNS01-T, and Bortezomib Results in Synergistic Cytotoxicity In Vitro and In Vivo in Multiple Myeloma 7:30 a.m. May 14, 2013 - BusinessWire


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us